Personalized Medicine in lung Cancer

The era of personalized treatment for lung cancer will involve a comprehensive genomic characterization of adenocarcinoma, squamous-cell carcinoma, and small-cell carcinoma into various subtypes. Precision medicine is to develop treatments that exploit weak spots in tumor cells to destroy only the cancer cells (as compared to traditional chemotherapy and radiation). Weak spots have been found in two genes, EGFR and ALK, both found in adenocarcinoma NSCLC.

  • Lung cancer surgery
  • Management of Chemotherpay
  • Non-smallcell lung cancer
  • Pathogenesis
  • Lung cancer clinical trials and research

Related Conference of Personalized Medicine in lung Cancer

May 9-10, 2019

17th European Pathology Congress

| Amsterdam, Netherlands
June 28-29, 2019

Breast Pathology and Cancer

Oslo, Norway
July 31 - August 1, 2019

International Conference on Surgical Pathology

Amsterdam,Netherlands
July 31- August 01, 2019

International Conference on Molecular Pathology

Amsterdam | Netherlands
August 21-22, 2019

17th Asia Pacific Pathology Congress

Singapore
November 08-09, 2019

18th Global Congress on Pathology

| San Francisco | United States
November 13-14, 2019

World Congress on Histopathology

Tokyo, Japan
November 25-26, 2019

2nd European Pathology and Infectious Disease Conference

Helsinki, Finland

Personalized Medicine in lung Cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in